Table 4.
Hande et al. Creatinine Clearance | Hande et al. Criteria Maintenance Dose of Allopurinol | Study Sample eGFR | Study Sample Initial Daily Dose of Allopurinol | mg |
---|---|---|---|---|
0 | 100 mg every 3 days | 0-9 | n | 22 |
mean | 240.91 | |||
dose ≤ Hande maintenance dose (%) | 0 | |||
10 | 100 mg every 2 days | 10-19 | n | 60 |
mean | 233.14 | |||
dose ≤ Hande maintenance dose (%) | 1.67 | |||
20 | 100 mg daily | 20-39 | n | 114 |
mean | 208.95 | |||
dose ≤ Hande maintenance dose (%) | 34.21 | |||
40 | 150 mg daily | 40-59 | n | 245 |
mean | 236.35 | |||
dose ≤ Hande maintenance dose (%) | 29.8 | |||
60 | 200 mg daily | 60-79 | n | 471 |
mean | 244.46 | |||
dose ≤ Hande maintenance dose (%) | 35.46 | |||
80 | 250 mg daily | 80-99 | n | 892 |
mean | 249.58 | |||
dose ≤ Hande maintenance dose (%) | 32.96 | |||
100 | 300 mg daily | 100-119 | n | 909 |
mean | 247.34 | |||
dose ≤ Hande maintenance dose (%) | 95.93 | |||
120 | 350 mg daily | 120-139 | n | 389 |
mean | 253.09 | |||
dose ≤ Hande maintenance dose (%) | 94.86 | |||
140 | 400 mg daily | 140+ | n | 20 |
mean | 250 | |||
dose ≤ Hande maintenance dose (%) | 95 |